Who owns Catalyst Biosciences?
- CUSIP Number: 14888d208
Tip: Access positions for across all investors
Analyze quarterly positions in Catalyst Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Catalyst Biosciences stock
Who bought or sold Catalyst Biosciences this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Advisory Services Network | 66.00 | $1.7k | 100% | Dec 2023 |
|
Who sold out of Catalyst Biosciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Vanguard Group | Sep 2023 | 207k | $100k |
Kynam Capital Management | Sep 2023 | 90k | $43k |
Nantahala Capital Management | Sep 2023 | 68k | $33k |
Barclays | Sep 2023 | 60k | $29k |
Parallax Volatility Advisers | Sep 2023 | 57k | $27k |
Citadel Advisors | Sep 2023 | 49k | $24k |
Hsbc Holdings | Sep 2023 | 33k | $16k |
Bank of America Corporation | Sep 2023 | 23k | $11k |
Two Sigma Securities | Sep 2023 | 20k | $9.7k |
Raymond James & Associates | Sep 2023 | 13k | $6.2k |
Arete Wealth Advisors | Sep 2023 | 11k | $5.2k |
Jpmorgan Chase & Co | Sep 2023 | 7.1k | $3.5k |
UBS Group | Sep 2023 | 5.1k | $2.4k |
Advisor Group Holdings | Sep 2023 | 390.00 | $188.019000 |
Bnp Paribas Arbitrage, Snc | Sep 2023 | 277.00 | $134.012600 |
Royal Bank of Canada | Sep 2023 | 253.00 | $0 |
Wells Fargo & Company | Sep 2023 | 201.00 | $97.002600 |